Skip to content
★ Sign in to follow
DA

Dario A. Paggiarino

Directeur Médical
EyePoint, Inc.
Total declarations
65
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (12 ops.)
€2.6M

Latest filing published 02 Apr 2024 for EyePoint, Inc..

Filing timeline

BuySale
Dario A. Paggiarino

Insider track record

Disclosed buys
0
Disclosed sells
12
Signal history

Dario A. Paggiarino: trading record in brief

Dario A. Paggiarino, listed as senior executive, appears in our data through filings on EyePoint, Inc. shares, published by SEC (Form 4). In total, 65 filings cover trades dated from 19 March 2018 to 30 March 2024.

Sales make up the whole of the open-market record (12 sales, €2.6M). Other entries cover 23 share grants and 30 option exercises. 2024 to date brings no purchases and 10 sales.

Most recently, on 2 April 2024, the filings show an option exercise in EyePoint, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Dario A. Paggiarino

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations64 total

25 of 64 declarations